啓弘生物科技股份有限公司
GMP Viral Vector
Manufacturing
GMP Viral Vector
Manufacturing
GMP Viral Vector
Manufacturing
-
AAV
AAV
-
Lentivirus
Lentivirus
-
Retrovirus
Retrovirus
-
Adenovirus
Adenovirus
State-of-the-art manufacturing facility
To Make The World Better
TFBS Bioscience Inc. is a certified and leading GMP Viral Vector Contract Development and Manufacturing Organization in Asia-Pacific and the first specialist viral vector provider in Taiwan.
With the expertise in manufacturing and comprehensive testing services, we always stand by our clients and help them clarify their needs and what should be done through continuous communication.
We are proud of our total solution service and flexible scheduling that consistently supports our clients to get their products into the market as quickly as possible.
Testing
Cell Bank Characterization
The pivotal step to ensure the safety of the biopharmaceutical product is to perform characterization and biological safety testing of the cell line.
Studies of Viral Clearance
The pivotal step to ensure the safety of the biopharmaceutical product is to perform characterization and biological safety testing of the cell line.
Bulk Lot Release Testing
The pivotal step to ensure the safety of the biopharmaceutical product is to perform characterization and biological safety testing of the cell line.
Preclinical and Clinical Samples Analysis
The pivotal step to ensure the safety of the biopharmaceutical product is to perform characterization and biological safety testing of the cell line.
Assay Development in vitro and in vivo
The pivotal step to ensure the safety of the biopharmaceutical product is to perform characterization and biological safety testing of the cell line.
Animal test
The pivotal step to ensure the safety of the biopharmaceutical product is to perform characterization and biological safety testing of the cell line.
Microbiological test
The pivotal step to ensure the safety of the biopharmaceutical product is to perform characterization and biological safety testing of the cell line.
News
Center for Drug Evaluation (CDE) to visit TFBS Bioscience, Inc.
Center for Drug Evaluation (CDE) to visit TFBS Bioscience, Inc.
We are honored to invite the Center for Drug Evaluation (CDE) to visit TFBS Bioscience, Inc. GMP viral vector manufacturing facility. It is a tremendous experience to exchange different experts' opinions and profoundly and widely discuss cell & gene therapy regulations.
2022-04-29
TFBS received the official approval letter from US FDA for the pre-approval inspection (PAI)
TFBS received the official approval letter from US FDA for the pre-approval inspection (PAI)
The US FDA completed a pre-approval inspection (PAI) of TFBS Bioscience’ brand new GMP testing facility on April 22, 2022. No 483 observation is cited. The positive outcome adds further assurance for our newly-established GMP testing business.
2022-04-22
Be Partnered With TFBS
We envision that TFBS Bioscience will soon become a leading brand in Asia for biological analysis.
